相似文献
1
Two-sample tests of area-under-the-curve in the presence of missing data.
Int J Biostat. 2008 Jan 17;4(1):Article 1. doi: 10.2202/1557-4679.1068.
2
Testing for associations with missing high-dimensional categorical covariates.
Int J Biostat. 2008 Sep 29;4(1):Article 18. doi: 10.2202/1557-4679.1102.
3
A Bayesian framework for intent-to-treat analysis with missing data.
Biometrics. 1998 Mar;54(1):265-78.
4
Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?
Trials. 2016 Jul 22;17:341. doi: 10.1186/s13063-016-1473-3.
5
Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
Contemp Clin Trials. 2006 Dec;27(6):506-17. doi: 10.1016/j.cct.2006.07.003. Epub 2006 Jul 25.
6
Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
J Biopharm Stat. 2000 Nov;10(4):447-55. doi: 10.1081/BIP-100101977.
7
Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
J Biopharm Stat. 2011 Jan;21(1):77-93. doi: 10.1080/10543406.2010.494267.
8
Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing outcomes.
Biostatistics. 2003 Oct;4(4):495-512. doi: 10.1093/biostatistics/4.4.495.
9
Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
PLoS One. 2015 Apr 24;10(4):e0124381. doi: 10.1371/journal.pone.0124381. eCollection 2015.
10
Missing data mechanisms in a dose-finding adaptive trial.
J Biopharm Stat. 2012;22(2):329-37. doi: 10.1080/10543406.2010.536871.
引用本文的文献
1
Analyzing Longitudinally Collected Viral Load Measurements in Youth With Perinatally Acquired HIV Infection: Problems and Possible Remedies.
Am J Epidemiol. 2022 Sep 28;191(10):1820-1830. doi: 10.1093/aje/kwac125.
2
A mixed effects model for analyzing area under the curve of longitudinally measured biomarkers with missing data.
Pharm Stat. 2021 Nov;20(6):1249-1264. doi: 10.1002/pst.2146. Epub 2021 Jun 20.
3
Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial.
Trials. 2018 Apr 27;19(1):259. doi: 10.1186/s13063-018-2610-y.
4
Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times.
Biometrics. 2013 Sep;69(3):732-40. doi: 10.1111/biom.12064. Epub 2013 Jul 17.
5
Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.
J Am Stat Assoc. 2012;107(498):542-554. doi: 10.1080/01621459.2011.646932. Epub 2012 Jul 24.
本文引用的文献
1
Combining dependent tests for linkage or association across multiple phenotypic traits.
Biostatistics. 2003 Apr;4(2):223-9. doi: 10.1093/biostatistics/4.2.223.
2
Linear mixed models with flexible distributions of random effects for longitudinal data.
Biometrics. 2001 Sep;57(3):795-802. doi: 10.1111/j.0006-341x.2001.00795.x.
3
A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.
J Pharmacokinet Biopharm. 1978 Feb;6(1):79-98. doi: 10.1007/BF01066064.
Zotero 插件